Utility of second-look ultrasound in the management of incidental enhancing lesions detected by breast MR imaging

Abstract

Second-look US is a reliable problem-solving tool in identifying and characterising most incidental MRI findings. It contributes to accurately selecting the cases in which MRI-guided biopsy is required.

Comparative sonographic review of benign and malignant breast masses

“…This in agreement with Nothacker et al, [13] with a summarized cohort study on the role of ultrasound in the framework of malignant cancer screening. Our observations are parallel with Abe et al [14] in which not all breast masses were declared cancerous. Ultrasound is blamed for many wrong diagnoses in confirmed (earlier termed: suspicious) masses.…”

“…It should be noted that ultrasound sometimes affirms MRI findings in breast cancer thereby demonstrating obscure lesions of BI-RADS grade 3 and 2 as stated by Carbognin et al when suspicion level in high. [4] Irrespective of were the masses are located, recommendation of mastectomies is left for general surgeons, beyond the scope of this review. 2 Criteria for ultrasound breast mass identification II BI-RADS [5] criteria employed in classification was obtained from evidence based on frozen sonograms.…”

MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging

“…As reported by other studies [17][18][19][20], second-look US is the fi rst reasonable approach for identifying and characterising lesions incidentally detected on MR imaging. In our series, second-look US resolved the management of a large majority (73%) of MR-visible lesions, a percentage higher than reported in other studies [17,18].…”

Additional findings at preoperative MRI: a simple golden rule for a complex problem?

“…This requires not only to be familiar with (supine) breast US but also with (prone) breast MRI as well as with the different lesion location at the two imaging techniques. Six recent studies reported percentages of US correlate for initially MR-detected findings variable from 46% to 82% [17][18][19][20][21][22]. Pooling their results, we have a total of 1,208 findings, 759 of them with a US correlate (63%).…”